Call us at +1-661-336-9555

cart

As the pace of technological innovation and evolution becomes more intense, there is a critical need for computer system validation, 21 CFR Part 11 (Electronic Records and Electronic Signatures) compliance, and data integrity assurance to continue in environments where AI is becoming prevalent.

FDA became alarmed by the lack of compliance to meet data integrity and Part 11 requirements during the last decade. Out of compliance citations during this period, including Form 483s and Warning Letters have skyrocketed. But why?

Based on discussions with clients and stakeholders at conferences and meetings, it has become more and more obvious that most of the performers in industry are under management pressure to do more work with fewer resources and in less time. This continues to lead performers to seek faster and easier ways to get the work done, causing them to rush through their work, resulting in unforced errors, and leading some to even take shortcuts that could lead to findings of fraud. Being optimistic about this, it also opens the door for more serious conversation around the use of AI and other technologies in software development, testing, and support. This is compounded further by the greater efficiencies promised by following CSA and removing work that does not add value while assuring risk is appropriately assessed and mitigated.

As we find ourselves in the midst of technology and compliance revolutions, It is time to prepare ourselves and be ready to leverage them to deliver quality products that meet the needs of consumers. Providing consumers with newer, safer, and more innovative and effective products is key to both FDA’s and industry’s focus on public safety.


  • Learn about Artificial Intelligence (AI) and Machine Learning (ML) and how they can be incorporated into computer system software used in FDA-regulated activities
  • Learn the best approach to validating and maintaining computer systems that incorporate AI and ML technology
  • Understand the challenges of using AI and ML in computer systems used in FDA-regulated activities
  • Learn about traditional Computer System Validation (CSV) and the more current draft guidance from FDA on Computer Software Assurance (CSA)
  • Learn about GAMP®5, 2nd Edition and how it aligns with both CSA and with AI and ML solutions
  • Learn about 21 CFR Part 11 requirements for FDA compliance and a streamlined approach to ensuring systems are fully tested/verified during validation
  • Learn about data integrity requirements for FDA compliance and a streamlined approach to ensuring systems are fully tested/verified during validation
  • Learn about how to comply with FDA while using Commercial Off-the-Shelf (COTS) software applications, cloud-based systems and Software-as-a-Service (SaaS) solutions
  • Learn about current FDA compliance trends
  • Learn about current industry best practices
  • Q&A

  • Artificial Intelligence (AI)
  • Machine Learning (ML)
  • Large Language Models (LLMs), such as ChatGPT
  • FDA Compliance for Computer System Validation
  • Traditional Computer System Validation (CSV)
  • Computer Software Assurance (CSA)
  • System Development Life Cycle (SDLC) Methodology
  • GAMP®5, 2nd Edition
  • GAMP®5 Software Categories
  • 21 CFR Part 11, FDA Guidance for Using Electronic Records/Electronic Signatures in Regulated Computer Systems
  • Data Integrity Compliance
  • Critical Thinking
  • Risk Assessment
  • Risk-Based Approach to Validation
  • Commercial-Off-the-Shelf (COTS) Software
  • Software-as-a-Service (SaaS) Solutions
  • Cloud Services
  • Automated Testing
  • Systems and Organizational Control (SOC) Certification
  • Vendor Audit
  • Periodic System Review
  • FDA Compliance Trends
  • Current Industry Best Practices
  • Q&A.

Providing safe and effective medical devices, drugs, and other FDA-regulated products is in the best interests of all those involved in the development, manufacturing, testing, and distribution of these products. Current industry drivers, including the rising demand for healthcare, expansion of specialty medicines & physician shortages require key strategies to alleviate pressures & accelerate the delivery of safe & effective products to the marketplace. As demand surges & complexity of cases requires approaches leveraging the latest medical knowledge, rapid access to accurate information is essential to quality.
Only by leveraging the latest in innovative technology will the industry catch up to where delivery is meeting demand. Along with companies, FDA has begun pilot programs using these technologies and is working to develop the appropriate regulatory framework to ensure products are safe & effective. Several discussion papers have been issued over the last few years & updated based on stakeholder feedback. Ultimately, these will be key elements for driving success.
We will compare traditional Computer System Validation (CSV) with Computer Software Assurance (CSA), the latter of which is the subject of FDA’s September 2022 draft guidance for industry. We will talk about the changes in the newer GAMP®5, 2nd Edition & how these align with CSA. While CSA remains a draft guidance, it will likely be finalized in the near future & companies must be prepared.
In addition to technology, we will discuss a variety of current trends in FDA compliance & enforcement. Over the last decade, we have seen an increase in citations related to 21 CFR Part 11 (electronic records/signatures) & data integrity (ALCOA+ principles) deficiencies. Laboratory areas have been the subject of many FDA findings, particularly around audit trail management & use, risk assessment, access controls & security.

  • Information Technology (IT) Analysts
  • IT Software Developers & Testers
  • IT Support Staff
  • IT Security Staff
  • QC/QA Managers and Analysts
  • Production Managers and Supervisors
  • Supply Chain Managers and Supervisors
  • Clinical Data Managers and Scientists
  • Compliance Managers and Auditors
  • Lab Managers and Analysts
  • Computer System Validation Specialists
  • GMP, GLP, GCP Training Specialists
  • Business Stakeholders using Computer Systems regulated by FDA
  • Regulatory Affairs Personnel
  • Consultants in the Life Sciences and Tobacco Industries
  • Interns working at the companies listed above
  • College students attending schools and studying computer system validation, regulatory affairs/matters (related to FDA) or any other discipline that involves adherence to FDA regulatory requirements.

Carolyn Troiano has more than 35 years of experience in the tobacco, pharmaceutical, medical device and other FDA-regulated industries. She has worked directly, or on a consulting basis, for many of the larger pharmaceutical and tobacco companies in the US and Europe, developing and executing compliance strategies and programs. Carolyn is currently active in the Association of Information Technology Professionals (AITP), and Project Management Institute (PMI) chapters in the Richmond, VA area.

During her career, Carolyn worked directly, or on a consulting basis, for many of the larger pharmaceutical companies in the US and Europe. She developed validation programs and strategies back in the mid-1980s, when the first FDA guidebook was published on the subject, and collaborated with FDA and other industry representatives on 21 CFR Part 11, the FDA’s electronic record/electronic signature regulation.

View all trainings by this speaker
 
Live Webinar

Live + Recorded Session

Get unlimited access to the link for six months for one participant, from the date of webinar completion.

$269

Live + Transcript

Get to attend the LIVE Session and also receive a PDF copy of the Transcript only after the completion of the LIVE webinar.

$249

Live + USB

Free shipment within 15 Working Days from the date of webinar completion.*

$399

On Demand

Transcript

PDF Transcript of the Training which are available once the webinar is completed.(Transcript for single user only)

$149

Downloadable Recorded Session

Get unlimited access to the link for six months.

$219

USB

Free shipment within 15 Working Days, from the date of webinar completion.*

$299

Group Session

Group Session Participants + Recorded

Live Session with unlimited participants. Invite any number of attendees to join.

$599

 

Upcoming Webinars